<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Surgery</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B0E0E482-B6A7-4461-BEF8-24FE249A1158"><gtr:id>B0E0E482-B6A7-4461-BEF8-24FE249A1158</gtr:id><gtr:firstName>Roger</gtr:firstName><gtr:otherNames>Arnold</gtr:otherNames><gtr:surname>Pedersen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/19564F2D-FB00-4F3E-B119-57D7A97648B8"><gtr:id>19564F2D-FB00-4F3E-B119-57D7A97648B8</gtr:id><gtr:firstName>Stefano</gtr:firstName><gtr:surname>Pluchino</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600275"><gtr:id>657AF774-1ED6-4B20-96E3-148E3AA5826F</gtr:id><gtr:title>Mechanisms of Activin/Nodal signalling in pluripotency and differentiation of human embryonic stem cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600275</gtr:grantReference><gtr:abstractText>Stem cells are remarkable in having the capacity to undergo specialisation into distinct tissue types, such as blood or skin. In addition, many stem cells are capable of self-renewal during cell division, so that they not only generate a specialised cell but also generate another stem cell. Our bodies are thereby able to retain their tissue-specific stem cells (such as those responsible for generating blood or skin) for our entire lifetimes. Such adult stem cells are generally thought to generate only a few types of cells, related to the specific tissue that they are derived from and are responsible for maintaining. Another type of stem cell can be derived from early stages of human development, namely from surplus embryos that arise in the treatment of human infertility using in vitro fertilisation. Such spare embryos, donated under informed consent by patients who have completed their therapies, are capable of generating embryonic stem cells when grown in petri dish. These stem cells are particularly interesting because they appear to have the ability to specialise into all of the tissue types in the entire body. 

The current proposal is to investigate the molecular details of how human embryonic stem cells maintain their pluripotency, and how the biochemical information that is responsible for starting their journey on the path to specialisation actually works.</gtr:abstractText><gtr:technicalSummary>In order to achieve the therapeutic potential of human embryonic stem cells, it will be necessary to scale up their growth in pristine conditions, and to generate significant quantities of clinically useful cell types. These goals will require an understanding of the mechanisms of pluripotency and differentiation in these cells. Current information indicates that human embryonic stem cells differ from their mouse counterparts in this regard. We therefore propose to investigate how the growth factors Activin and Nodal and their Smad signalling pathway act first to maintain pluripotency and then to induce differentiation into the precursors of mesoderm and endoderm. 

Our hypothesis is that a distinct set of Smad binding partners are involved in maintaining pluripotency, and our first objective is to identify and functionally evaluate them. We also propose studies of the forkhead transcription factor, FoxH1, to determine how it functions during mesoderm and endoderm differentiation. Our third objective is to identify the downstream target genes through which these Smad binding partners exert their effects. These studies should provide essential insights into how Activin, Nodal and related growth factors are able to have varied developmental roles and should reveal how they can be used to generate homogeneous populations of either pluripotent or differentiated human cells for therapeutic use.</gtr:technicalSummary><gtr:fund><gtr:end>2012-02-11</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-02-12</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1225913</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Development and Neuroscience</gtr:department><gtr:description>Neuroscience collaboration</gtr:description><gtr:id>CFBDA9C1-187C-495B-B1A1-88952E0F47C4</gtr:id><gtr:impact>See co-authored paper with Lupo and Harris.
Multidisciplinary: Neuroscience and stem cells</gtr:impact><gtr:outcomeId>QXk7yXjDxEv-1</gtr:outcomeId><gtr:partnerContribution>Provision of postdoctoral fellow for collaborative effort.</gtr:partnerContribution><gtr:piContribution>We provided space and stem cell culture expertise for the collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>103878</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Studentship</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>CDFCBB1B-C681-49C3-B2A0-524252F0D353</gtr:id><gtr:outcomeId>qqsa182gezp0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We discovered methods for inducing the differentiation of pluripotent human stem cells into neural, mesoderm/endoderm, and extraembryonic tissues using feeder-free, serum-free conditions.</gtr:description><gtr:grantRef>G0600275</gtr:grantRef><gtr:id>54C29ED6-0474-4403-A74C-E3942E4774D9</gtr:id><gtr:impact>None</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>UN9Cu3s33TJ</gtr:outcomeId><gtr:patentId>WO2008056166</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Chemically defined differentiation</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>This invention relates to the isolation and propagation of pluripotent cells isolated from the mammalian
late epiblast layer, termed Epiblast Stem Cells' (EpiSCs). These cells are useful in a range of
applications.</gtr:description><gtr:grantRef>G0600275</gtr:grantRef><gtr:id>DF694682-9A12-4BAF-8249-6B69F8559DB0</gtr:id><gtr:impact>None to date</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>Rx9r5o6XLsu</gtr:outcomeId><gtr:patentId>WO2008056173</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Pluripotent cells from the mammalian late epiblast layer</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Moreau T, Trotter MWB, Ouwehand W and Pedersen RA filed this application regarding a method for generating human megakaryocytes from human pluripotent stem cells using direct programming.</gtr:description><gtr:grantRef>G0600275</gtr:grantRef><gtr:id>6507A6BB-4F74-427A-B46C-78165C406F12</gtr:id><gtr:impact>None to date</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>FhHKfLvSsPB</gtr:outcomeId><gtr:patentId>WO</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Transcription factor mediated programming towards megakaryocytes</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Sinha S, Cheung C, Bernardo A and Pedersen R. filed this application regarding a method for generating embryonic region type-specific smooth muscle cells from pluripotent stem cells in vitro.</gtr:description><gtr:grantRef>G0600275</gtr:grantRef><gtr:id>AF2ED25C-8978-4CAA-883C-2DFB5FF12D65</gtr:id><gtr:impact>None to date</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>ecs2Kvuh1yA</gtr:outcomeId><gtr:patentId>PCT/GB2012/051334</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Populations of smooth muscle cells of specific embryonic lineages</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Definigen</gtr:companyName><gtr:description>Research and experimental development on biotechnology</gtr:description><gtr:id>11FB9398-4B92-4351-B5E8-AEFFF023AAB1</gtr:id><gtr:impact>Supplying chemically-defined medium and hepatocytes produced therefrom for drug discovery and toxicity testing.</gtr:impact><gtr:outcomeId>544fe0fb0f9665.39232534</gtr:outcomeId><gtr:url>http://www.definigen.com/</gtr:url><gtr:yearCompanyFormed>2011</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>829278B4-A6B6-4DDA-9865-38F990FFE407</gtr:id><gtr:title>Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_13723_13_17572666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17F7F650-58BD-4C97-A786-67E519467F67</gtr:id><gtr:title>Status of genomic imprinting in epigenetically distinct pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66eb9cc0e7d5509969cc13671b3df32e"><gtr:id>66eb9cc0e7d5509969cc13671b3df32e</gtr:id><gtr:otherNames>Sun B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>n4dY1CbuLDX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EFEF667-A376-4BA2-A8F4-76D3253A5012</gtr:id><gtr:title>International coordination of large-scale human induced pluripotent stem cell initiatives: Wellcome Trust and ISSCR workshops white paper.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2e5d805263a390d924ccc3b6b5ebf9"><gtr:id>7e2e5d805263a390d924ccc3b6b5ebf9</gtr:id><gtr:otherNames>Soares FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>56dd794eacf129.43211575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4B6938A-6E3B-4FBD-A074-0B92E863283D</gtr:id><gtr:title>Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4815fef9147bc9bc97b727b0059b4c8a"><gtr:id>4815fef9147bc9bc97b727b0059b4c8a</gtr:id><gtr:otherNames>Cheung C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_13723_23_22252507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4450C0AE-4BF0-46B1-A1D7-A7356EDBB03C</gtr:id><gtr:title>Development and applications of single-cell transcriptome analysis.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a232e0a3660b49b0d8b24aa6e95f94f"><gtr:id>3a232e0a3660b49b0d8b24aa6e95f94f</gtr:id><gtr:otherNames>Tang F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>12AC2F1E_412AC2F1E_4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D3F8EAB-471B-4009-AEB1-659D61EA832B</gtr:id><gtr:title>Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1857cecfd381d325a3c8a449d03b339d"><gtr:id>1857cecfd381d325a3c8a449d03b339d</gtr:id><gtr:otherNames>Kim K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_13723_13_18371368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2A9BB36-9AAD-4115-BF02-A34E537F0337</gtr:id><gtr:title>Out with the old, in with the new?</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dfccec05113a84c6269fa4c570f2bd9"><gtr:id>4dfccec05113a84c6269fa4c570f2bd9</gtr:id><gtr:otherNames>Pedersen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_13723_13_19556472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62FD4610-73FF-4201-B07C-1A063D8ACFF2</gtr:id><gtr:title>Nuclear transfer-derived epiblast stem cells are transcriptionally and epigenetically distinguishable from their fertilized-derived counterparts.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b48ca422642a80f8145e05da19470f39"><gtr:id>b48ca422642a80f8145e05da19470f39</gtr:id><gtr:otherNames>Maruotti J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>D396099D_FD396099D_F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C76576B6-078E-45DB-8C22-92C8042539BD</gtr:id><gtr:title>BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df917757ae52f571dc19817fa1deebff"><gtr:id>df917757ae52f571dc19817fa1deebff</gtr:id><gtr:otherNames>Bernardo AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm-13723-21816365</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CBA21F4-C4F0-4109-BEFC-D25FBEB04949</gtr:id><gtr:title>Human pre-implantation embryo development.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/388947ba1da47ee468f9740e12b6d5c1"><gtr:id>388947ba1da47ee468f9740e12b6d5c1</gtr:id><gtr:otherNames>Niakan KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_13723_23_22318624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D18EA735-8072-4ACA-BA94-00459CAE9EC9</gtr:id><gtr:title>MeCP2 dependent heterochromatin reorganization during neural differentiation of a novel Mecp2-deficient embryonic stem cell reporter line.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/634e91149636c5b31aca6877febb00d2"><gtr:id>634e91149636c5b31aca6877febb00d2</gtr:id><gtr:otherNames>Bertulat B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13723_23_23112857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16A3AD17-5D00-4611-A8FF-0F4CD59D28CA</gtr:id><gtr:title>Biphasic induction of Pdx1 in mouse and human embryonic stem cells can mimic development of pancreatic beta-cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df917757ae52f571dc19817fa1deebff"><gtr:id>df917757ae52f571dc19817fa1deebff</gtr:id><gtr:otherNames>Bernardo AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_13723_13_19056911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E00AD26-37A3-45C1-97AD-8E250622B2E8</gtr:id><gtr:title>Morphological and electrical properties of oligodendrocytes in the white matter of the corpus callosum and cerebellum.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d65487e56b27b5c3db363045fc4296e"><gtr:id>8d65487e56b27b5c3db363045fc4296e</gtr:id><gtr:otherNames>Bakiri Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>87D9376E_087D9376E_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2018A465-33A5-4DC6-BA9F-F7B9404DC539</gtr:id><gtr:title>Derivation of pluripotent epiblast stem cells from mammalian embryos.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/778ae904565ee16b9ba73db19f16f7e5"><gtr:id>778ae904565ee16b9ba73db19f16f7e5</gtr:id><gtr:otherNames>Brons IG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_13723_13_17597762</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86B61960-A0BD-4176-9C6A-A1665B84D5CC</gtr:id><gtr:title>SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac1dd832971703c510fb507db3105ca9"><gtr:id>ac1dd832971703c510fb507db3105ca9</gtr:id><gtr:otherNames>Chng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>CDEA9864_CCDEA9864_C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71C360CC-8037-4DE3-9CB3-5C020207C267</gtr:id><gtr:title>LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2eb0c67a6d1f18bcb597cc74d66965f"><gtr:id>c2eb0c67a6d1f18bcb597cc74d66965f</gtr:id><gtr:otherNames>Griffiths DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>gZYbms7JrE4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ACF7808-A171-48F3-8082-5175745102EE</gtr:id><gtr:title>Brachyury and SMAD signalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a55e2f0c561deef1299810a7bd7ca3c"><gtr:id>2a55e2f0c561deef1299810a7bd7ca3c</gtr:id><gtr:otherNames>Faial T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>5450b129e09b80.03987550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC4C1CEF-78CB-4266-B6E7-FD7898BC1776</gtr:id><gtr:title>Multiple roles of Activin/Nodal, bone morphogenetic protein, fibroblast growth factor and Wnt/?-catenin signalling in the anterior neural patterning of adherent human embryonic stem cell cultures.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de98e60228b2f89b7fca77d65ccdde70"><gtr:id>de98e60228b2f89b7fca77d65ccdde70</gtr:id><gtr:otherNames>Lupo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_13723_23_23576785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1052A1F7-3904-47D0-AEE1-A4EB12CE1B0E</gtr:id><gtr:title>Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b898cfb81e4f4b00370f8b5f79a13a3"><gtr:id>6b898cfb81e4f4b00370f8b5f79a13a3</gtr:id><gtr:otherNames>Fordham RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_13723_23_24139758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52A4D51C-3C7B-4C04-BEA3-7A8A830E19D1</gtr:id><gtr:title>Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72666955fd412d26c94ad43b8ed92e73"><gtr:id>72666955fd412d26c94ad43b8ed92e73</gtr:id><gtr:otherNames>Smith JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>pm_13723_13_18022151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FEF0F78-2FB8-4B16-A66D-2E5AA1B6CE76</gtr:id><gtr:title>NANOG and CDX2 pattern distinct subtypes of human mesoderm during exit from pluripotency.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/faf2099f12c8e0c0b914c7948506f1db"><gtr:id>faf2099f12c8e0c0b914c7948506f1db</gtr:id><gtr:otherNames>Mendjan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>StmKBX9y5oU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>319A8E21-F882-4554-BF78-C683CE764595</gtr:id><gtr:title>Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72666955fd412d26c94ad43b8ed92e73"><gtr:id>72666955fd412d26c94ad43b8ed92e73</gtr:id><gtr:otherNames>Smith JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_13723_13_18024421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E58C470-ED5F-4B31-AE77-EB060BF8417B</gtr:id><gtr:title>Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1546-3222</gtr:issn><gtr:outcomeId>pm_13723_23_21030519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33F7F6EF-1642-4DDD-B034-4F663095C6D9</gtr:id><gtr:title>Maternal Argonaute 2 is essential for early mouse development at the maternal-zygotic transition.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b57d0f03ba5d28eaf2d3e218f269225"><gtr:id>3b57d0f03ba5d28eaf2d3e218f269225</gtr:id><gtr:otherNames>Lykke-Andersen K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>3BA05779_83BA05779_8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2421EC7-4AF5-4187-AAB4-977555DE66C7</gtr:id><gtr:title>Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccd67eaa410f1dafd57772937ce7d30c"><gtr:id>ccd67eaa410f1dafd57772937ce7d30c</gtr:id><gtr:otherNames>Brown S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_13723_23_21630377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80BE6E4B-5DFE-49D2-A3D5-863BC8598725</gtr:id><gtr:title>Conversion from mouse embryonic to extra-embryonic endoderm stem cells reveals distinct differentiation capacities of pluripotent stem cell states.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6de91b5b849e133ff09908f93adb38bf"><gtr:id>6de91b5b849e133ff09908f93adb38bf</gtr:id><gtr:otherNames>Cho LT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_13723_23_22791892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9252CC38-9863-434F-A3E9-A247CA68F8C2</gtr:id><gtr:title>Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d2c43929db3bd27a0bde11ff4f84bc9"><gtr:id>1d2c43929db3bd27a0bde11ff4f84bc9</gtr:id><gtr:otherNames>Evans AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13723_23_22479388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3E9C8D-272C-45AA-A3C4-32317B0127A3</gtr:id><gtr:title>Essential role for Argonaute2 protein in mouse oogenesis.</gtr:title><gtr:parentPublicationTitle>Epigenetics &amp; chromatin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1859fe5a4e47c79bedffbedebcd7a5cb"><gtr:id>1859fe5a4e47c79bedffbedebcd7a5cb</gtr:id><gtr:otherNames>Kaneda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1756-8935</gtr:issn><gtr:outcomeId>56D48F00_B56D48F00_B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B62A42F-384C-4901-ACEA-03D2FA6965B9</gtr:id><gtr:title>Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74a2ddaf859c3451a337002cbcb2ed06"><gtr:id>74a2ddaf859c3451a337002cbcb2ed06</gtr:id><gtr:otherNames>Pawlowski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>56dd631af15870.16551247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F076FBC4-3F14-431F-BF5C-E10181DF6B43</gtr:id><gtr:title>Directed differentiation of embryonic origin-specific vascular smooth muscle subtypes from human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4815fef9147bc9bc97b727b0059b4c8a"><gtr:id>4815fef9147bc9bc97b727b0059b4c8a</gtr:id><gtr:otherNames>Cheung C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>pm_13723_23_24675733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AC5B4DD-8B58-46C3-83D8-2B8CF936F678</gtr:id><gtr:title>Conditional gene expression in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d39425d881d3ca4554b5e13958c9ac"><gtr:id>e5d39425d881d3ca4554b5e13958c9ac</gtr:id><gtr:otherNames>Vallier L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_13723_13_17322103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC9764FC-0D4F-490B-99A1-D94C18C152C6</gtr:id><gtr:title>Applications of nuclear reprogramming and directed differentiation in vascular regenerative medicine.</gtr:title><gtr:parentPublicationTitle>New biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10274cc67463fd983435c7ccd6a33caf"><gtr:id>10274cc67463fd983435c7ccd6a33caf</gtr:id><gtr:otherNames>Rana AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1871-6784</gtr:issn><gtr:outcomeId>53b0378b3c9e09.94003442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F715FEBA-81EF-4821-8BE8-5DE34088C6CF</gtr:id><gtr:title>Activin/nodal signaling and pluripotency.</gtr:title><gtr:parentPublicationTitle>Vitamins and hormones</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac1dd832971703c510fb507db3105ca9"><gtr:id>ac1dd832971703c510fb507db3105ca9</gtr:id><gtr:otherNames>Chng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0083-6729</gtr:issn><gtr:outcomeId>C8523BA2_1C8523BA2_1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57E738BE-DAE4-4230-9A9F-0EF86B07D900</gtr:id><gtr:title>Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2e5d805263a390d924ccc3b6b5ebf9"><gtr:id>7e2e5d805263a390d924ccc3b6b5ebf9</gtr:id><gtr:otherNames>Soares FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>56dd794f654160.50316312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C2B4394-02AC-4E15-AB83-EE24E5D5416C</gtr:id><gtr:title>Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/858a8c6848194ff348f0e6da31051b06"><gtr:id>858a8c6848194ff348f0e6da31051b06</gtr:id><gtr:otherNames>Wang JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>pm_13723_23_22773427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0015E46B-203B-40BB-9336-811FDB8AA1A9</gtr:id><gtr:title>The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86fd4e165085a7a1f5cf2793f6fa24e2"><gtr:id>86fd4e165085a7a1f5cf2793f6fa24e2</gtr:id><gtr:otherNames>Katsanou V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>BA213E6B_5BA213E6B_5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0293BFDC-3279-4312-A9AE-CD49B791569B</gtr:id><gtr:title>Pleiotrophin enhances clonal growth and long-term expansion of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e6173abfaac9ffe08f9c74c04960a74"><gtr:id>7e6173abfaac9ffe08f9c74c04960a74</gtr:id><gtr:otherNames>Soh BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_13723_13_17823238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFECFC50-5E9B-4D79-BE89-B406841B0A0F</gtr:id><gtr:title>Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25dc7ab01aa844ef9bd991db7b6b7115"><gtr:id>25dc7ab01aa844ef9bd991db7b6b7115</gtr:id><gtr:otherNames>Rugg-Gunn PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13723_13_17911167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EF07AE1-83DC-43DF-BDCC-553E41FBFFA7</gtr:id><gtr:title>NANOG and CDX2 pattern distinct subtypes of human mesoderm during exit from pluripotency.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/faf2099f12c8e0c0b914c7948506f1db"><gtr:id>faf2099f12c8e0c0b914c7948506f1db</gtr:id><gtr:otherNames>Mendjan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>544fd8cfd0ab88.90505803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79CFB74E-2F04-4747-8447-867FF6AE0388</gtr:id><gtr:title>NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76a7ee3a317a79691cee2ca64801a3a8"><gtr:id>76a7ee3a317a79691cee2ca64801a3a8</gtr:id><gtr:otherNames>Reynolds N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_13723_23_22560079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22F1E3CC-45BF-4C1C-B092-E5B49AAD2B50</gtr:id><gtr:title>An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence of poorly soluble drugs.</gtr:title><gtr:parentPublicationTitle>The AAPS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac0d26d48651d5caaefc732c720ad9aa"><gtr:id>ac0d26d48651d5caaefc732c720ad9aa</gtr:id><gtr:otherNames>Dickinson PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-7416</gtr:issn><gtr:outcomeId>pm_13723_23_22374384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB9966C8-F005-48C4-AEA7-735153AA6542</gtr:id><gtr:title>Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d39425d881d3ca4554b5e13958c9ac"><gtr:id>e5d39425d881d3ca4554b5e13958c9ac</gtr:id><gtr:otherNames>Vallier L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>B4DCD1D1B3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>785380C1-6CD2-4C31-8E96-79F317FECCDC</gtr:id><gtr:title>Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91e5428631f9252c0ad8cf6a6b149207"><gtr:id>91e5428631f9252c0ad8cf6a6b149207</gtr:id><gtr:otherNames>Iyer D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>5675e1651f0e2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ACF9EC3-F013-40B0-9991-5820B5D23327</gtr:id><gtr:title>Tau acts as an independent genetic risk factor in pathologically proven PD.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80bdbfdd0b1d93ff7f53295d25d425e7"><gtr:id>80bdbfdd0b1d93ff7f53295d25d425e7</gtr:id><gtr:otherNames>Charlesworth G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_13723_23_22221882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49DC8E8E-AD2C-4761-9D2E-53110B337A24</gtr:id><gtr:title>Endothelial progenitor cells in pulmonary hypertension - dawn of cell-based therapy?</gtr:title><gtr:parentPublicationTitle>International journal of clinical practice. Supplement</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d937f5f0be2511cd86725eea834e5c4c"><gtr:id>d937f5f0be2511cd86725eea834e5c4c</gtr:id><gtr:otherNames>Toshner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1368-504X</gtr:issn><gtr:outcomeId>pm_13723_13_19958395</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A39B493A-932E-438E-AEE6-8D8FA602ECC2</gtr:id><gtr:title>Synthetic organs for regenerative medicine.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cab4fcfee543363478e46089afefdc76"><gtr:id>cab4fcfee543363478e46089afefdc76</gtr:id><gtr:otherNames>Pedersen RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_13723_23_22704499</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE918FE5-81E7-417A-B06B-65C267F4AC13</gtr:id><gtr:title>Naivet&amp;eacute; of the human pluripotent stem cell.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f00cc020aefd0bd2f8f7339a66c13bc"><gtr:id>1f00cc020aefd0bd2f8f7339a66c13bc</gtr:id><gtr:otherNames>Mascetti VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_13723_23_24406934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4039B8A8-FDA5-4966-A2AF-2FC19EF0410D</gtr:id><gtr:title>Human-Mouse Chimerism Validates Human Stem Cell Pluripotency.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f00cc020aefd0bd2f8f7339a66c13bc"><gtr:id>1f00cc020aefd0bd2f8f7339a66c13bc</gtr:id><gtr:otherNames>Mascetti VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>56dd6e5fd3b4c8.43735338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A39BD995-121D-422D-86B3-1201ABE6BF3A</gtr:id><gtr:title>Stem cell therapy for glaucoma: possibilities and practicalities.</gtr:title><gtr:parentPublicationTitle>Expert review of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e90e31283643d50f0bbf2e2c4bb9e18"><gtr:id>5e90e31283643d50f0bbf2e2c4bb9e18</gtr:id><gtr:otherNames>Johnson TV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1746-9899</gtr:issn><gtr:outcomeId>C5714564_9C5714564_9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E71A82C-7C76-42BB-A1FF-9C2CDD7234A0</gtr:id><gtr:title>Development and applications of single-cell transcriptome analysis</gtr:title><gtr:parentPublicationTitle>Nature Methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a232e0a3660b49b0d8b24aa6e95f94f"><gtr:id>3a232e0a3660b49b0d8b24aa6e95f94f</gtr:id><gtr:otherNames>Tang F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>12AC2F1E_412AC2F1E_4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3902BA-A7C5-498A-B6B0-59D60628E543</gtr:id><gtr:title>Differentiation of human embryonic stem cells in adherent and in chemically defined culture conditions.</gtr:title><gtr:parentPublicationTitle>Current protocols in stem cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d39425d881d3ca4554b5e13958c9ac"><gtr:id>e5d39425d881d3ca4554b5e13958c9ac</gtr:id><gtr:otherNames>Vallier L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1938-8969</gtr:issn><gtr:outcomeId>pm_13723_13_18770639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E14B299-072F-40CD-AAA6-359D40E7EC45</gtr:id><gtr:title>Stem cells. Epigenome disruptors.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4843181f21764df7133f54d6d304065d"><gtr:id>4843181f21764df7133f54d6d304065d</gtr:id><gtr:otherNames>Hemberger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_13723_23_21030637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8755A04E-C41C-427D-9C20-4E60423BF110</gtr:id><gtr:title>Investigating the feasibility of scale up and automation of human induced pluripotent stem cells cultured in aggregates in feeder free conditions.</gtr:title><gtr:parentPublicationTitle>Journal of biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2e5d805263a390d924ccc3b6b5ebf9"><gtr:id>7e2e5d805263a390d924ccc3b6b5ebf9</gtr:id><gtr:otherNames>Soares FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0168-1656</gtr:issn><gtr:outcomeId>pm_13723_23_24440272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>911CFF37-AAC9-4C32-B461-73A0D2553154</gtr:id><gtr:title>Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1d0d5d3b7e95bf82a9c0dd50b73a3af"><gtr:id>d1d0d5d3b7e95bf82a9c0dd50b73a3af</gtr:id><gtr:otherNames>Kim WR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>AF44A869_0AF44A869_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DFEE1C9-5BA4-49E0-949D-EA8AEA1FFD22</gtr:id><gtr:title>Human hypoblast formation is not dependent on FGF signalling.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11961079744545ff0447479385de0149"><gtr:id>11961079744545ff0447479385de0149</gtr:id><gtr:otherNames>Roode M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>1309973E_21309973E_2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600275</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>